Virometix: Virometix Closes CHF 7.5M Series B Funding Round
Virometix, a Schlieren, Switzerland-based...
Read full article »
Virometix develops and commercializes vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.
Read more